JAGX Stock: Jaguar Health Rose After Reported 2020 Financial Results
Mytesi's net sales and gross sales grew 64% and 148%, respectively, in 2020 compared to 2019.
www.investreader.com - April 01, 2021
JAGX Stock: Why Jaguar Health Stock Skyrocketed Monday
The stock has increased over 55% during intraday trading and finally closed higher 36%. so, what happened?
www.investreader.com - March 09, 2021
JAGX Stock: Why Popular Jaguar Health Is Climbing Today
JAGX stock is on the move today after Jaguar Health announced a plan to secure $5 million of funding. Here's what to know now.
investorplace.com - March 08, 2021
Is the Parabolic Rise of JAGX Stock Too Good to Be True?
JAGX stock has risen dramatically on positive sentiment about the potential for an expanded market for the company's core Mytesi drug.
investorplace.com - March 05, 2021
Jaguar Health Is on a Noble Mission But JAGX Stock Needs a Nudge
Jaguar Health is doing the right thing while JAGX stock is on the skids. It is falling into support, so there could be relief coming.
investorplace.com - March 03, 2021
JAGX Stock: What to Know as SPAC News Sends Jaguar Health Soaring
JAGX stock is on the move today after the popular company announced it had signed a memorandum of understanding for a SPAC deal.
investorplace.com - February 18, 2021